Library / Laws / 115th Congress / Senate Bills / S. 1052
S. 1052
To strengthen the use of patient-experience data within the benefit-risk framework for approval of new drugs.
| Print stage | Date | Size | ⠃ |
|---|---|---|---|
| Introduced in Senate | 2017-05-04 | 1.4K | ⠃⠗⠋ |
| Engrossed in Senate | — | 1.3K | ⠃⠗⠋ |
| rfh | 2017-08-04 | 1.4K | ⠃⠗⠋ |